Open Access

Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress‑induced apoptosis

  • Authors:
    • Xin‑Yi Sun
    • Han‑Jiao Qin
    • Ze Zhang
    • Ye Xu
    • Xiao‑Chun Yang
    • Dong‑Ming Zhao
    • Xiao‑Ning Li
    • Lian‑Kun Sun
  • View Affiliations

  • Published online on: November 19, 2015     https://doi.org/10.3892/mmr.2015.4580
  • Pages: 661-668
  • Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Previous studies have suggested that endoplasmic reticulum stress (ERS) is one of the mechanisms responsible for the pathogenesis of diabetic nephropathy (DN). Histone acetylation modification can regulate the transcription of genes and is involved in the regulation of ERS. Valproate (VPA), a nonselective histone deacetylase inhibitor, has been reported to have a protective role in kidney tissue injury, however, whether VPA can prevent DN remains to be elucidated. In the present study, it was found that VPA increases the expression of glucose‑regulated protein (GRP78) and reduces the protein expression of C/EBP‑homologous protein (CHOP), growth arrest and DNA‑damage‑inducible gene 153 and caspase‑12 in a rat model of DN. VPA can reduce renal cell apoptosis and alleviate proteinuria and alterations in serum creatinine. VPA also upregulates the acetylation level of histone H4 in the promoter of GRP78 and downregulates the acetylation level of histone H4 in the promoter of CHOP. Collectively, the data indicate that VPA can relieve ERS and reduce renal cell apoptosis, and thus attenuate renal injury in a rat model of DN by regulating the acetylation level of histone H4 in ERS‑associated protein promoters.
View Figures
View References

Related Articles

Journal Cover

January-2016
Volume 13 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sun XY, Qin HJ, Zhang Z, Xu Y, Yang XC, Zhao DM, Li XN and Sun LK: Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress‑induced apoptosis. Mol Med Rep 13: 661-668, 2016.
APA
Sun, X., Qin, H., Zhang, Z., Xu, Y., Yang, X., Zhao, D. ... Sun, L. (2016). Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress‑induced apoptosis. Molecular Medicine Reports, 13, 661-668. https://doi.org/10.3892/mmr.2015.4580
MLA
Sun, X., Qin, H., Zhang, Z., Xu, Y., Yang, X., Zhao, D., Li, X., Sun, L."Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress‑induced apoptosis". Molecular Medicine Reports 13.1 (2016): 661-668.
Chicago
Sun, X., Qin, H., Zhang, Z., Xu, Y., Yang, X., Zhao, D., Li, X., Sun, L."Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress‑induced apoptosis". Molecular Medicine Reports 13, no. 1 (2016): 661-668. https://doi.org/10.3892/mmr.2015.4580